About
Qlaris is advancing QLS-111, a novel topical ocular therapy designed to lower intraocular pressure through a unique mechanism of action. Unlike current treatments, QLS-111 selectively targets episcleral venous pressure (EVP) and enhances outflow distal to the trabecular meshwork.
This innovative approach may offer improved treatment options for conditions in which EVP is limited or pathological, including Normal Tension Glaucoma, Primary Open Angle Glaucoma, and glaucoma associated with Sturge-Weber Syndrome. QLS-111 may also be used alongside Minimally-Invasive Glaucoma Surgery (MIGS) devices to further optimize outcomes.
Dedham